CB-001(CymaBay therapeutics)

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCB-001(CymaBay therapeutics)
Drug Alias NameCB-001
ClassificationOther
Mechanisms of ActionFree fatty acid receptor 4 agonists
TargetsFree fatty acid receptor 4
Therapy Area/IndicationsLiver Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCymabay Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCymabay Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsLiver Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A